# NYLI Fiera SMID Growth Fund

NYLI Fiera SMID Growth Fund is a registered fund series of NEW YORK LIFE INVESTMENTS FUNDS TRUST (series S000080473). Net assets $232.4M as of 2026-04-30.

## Profile

- Series ID: S000080473
- Registrant: NEW YORK LIFE INVESTMENTS FUNDS TRUST
- LEI: 5493000ALHDIFU0STF84
- Net assets: $232.4M
- Total assets: $232.6M
- As of: 2026-04-30

## Advisers

- [New York Life Investment Management LLC (Advisor)](https://search.stillhousedata.com/firm/109591)
- [Fiera Capital Inc. (Subadvisor)](https://search.stillhousedata.com/firm/113638)

## Top holdings (76 reported)

_Showing 15 of 76 holdings by value._

| Holding | Ticker | Value | % of fund |
| --- | --- | --- | --- |
| [Argenx SE](https://search.stillhousedata.com/security/04016X101) | — | $8.2M | 351.94% |
| [BWX Technologies, Inc.](https://search.stillhousedata.com/security/05605H100) | — | $8.1M | 348.12% |
| [Curtiss-Wright Corp.](https://search.stillhousedata.com/security/231561101) | — | $7.6M | 328.24% |
| [Comfort Systems USA, Inc.](https://search.stillhousedata.com/security/199908104) | — | $7.2M | 311.54% |
| [Lattice Semiconductor Corp.](https://search.stillhousedata.com/security/518415104) | — | $6.4M | 276.58% |
| [EMCOR Group, Inc.](https://search.stillhousedata.com/security/29084Q100) | — | $6.4M | 275.62% |
| [Entegris, Inc.](https://search.stillhousedata.com/security/29362U104) | — | $6.4M | 274.73% |
| [Insmed, Inc.](https://search.stillhousedata.com/security/457669307) | — | $5.9M | 254.89% |
| JFrog Ltd. | — | $5.2M | 222.47% |
| [Stifel Financial Corp.](https://search.stillhousedata.com/security/860630102) | — | $5.1M | 218.08% |
| [Hubbell, Inc.](https://search.stillhousedata.com/security/443510607) | — | $4.6M | 196.99% |
| [EQT Corp.](https://search.stillhousedata.com/security/26884L109) | — | $4.6M | 196.08% |
| [Modine Manufacturing Co.](https://search.stillhousedata.com/security/607828100) | — | $4.4M | 189.76% |
| [Madrigal Pharmaceuticals, Inc.](https://search.stillhousedata.com/security/558868105) | — | $4.4M | 188.16% |
| [Neurocrine Biosciences, Inc.](https://search.stillhousedata.com/security/64125C109) | — | $4.3M | 184.60% |

## Net asset history

| Report date | Net assets |
| --- | --- |
| 2026-04-30 | $232.4M |
| 2026-01-31 | $318.4M |
| 2025-10-31 | $346.9M |
| 2025-07-31 | $345.9M |
| 2025-04-30 | $337.5M |
| 2025-01-31 | $398.6M |
| 2024-10-31 | $386.6M |
| 2024-07-31 | $400.3M |

## More

- [Registrant: NEW YORK LIFE INVESTMENTS FUNDS TRUST](https://search.stillhousedata.com/registrant/1469192)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/fund/S000080473.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.